Search
Descriptor English: Lansoprazole
Descriptor Spanish: Lansoprazol
Descriptor lansoprazol
Entry term(s) lansoprazoles
Scope note: Derivado 2,2,2-trifluoroetoxipiridil de timoprazol que se utiliza en la terapia de las ÚLCERAS GÁSTRICAS y el SÍNDROME DE ZOLLINGER-ELLISON. Esta droga inhibe el INTERCAMBIO ATPASA-H(+)-K(+) en las CÉLULAS PARIETALES GÁSTRICAS. El lansoprazol es una mezcla racémica de los isómeros (R)- y (S)-.
Descriptor Portuguese: Lansoprazol
Descriptor French: Lansoprazole
Entry term(s): 2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)benzimidazole
AG 1749
AG-1749
AG1749
Agopton
Bamalite
Lansol
Lansoprazol
Lansoprazole Sodium
Lansoprazoles
Lanzor
Monolitum
Ogast
Ogastro
Opiren
Prevacid
Prezal
Pro Ulco
Promeco
Sodium, Lansoprazole
Takepron
Ulpax
Zoton
Tree number(s): D02.886.640.074.249
D03.383.725.024.249
D03.633.100.103.034.249
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D064747
Scope note: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Anti-Ulcer Agents
Proton Pump Inhibitors
Registry Number: 0K5C5T2QPG
Public MeSH Note: 2014; LANSOPRAZOLE was indexed under 2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES 2007-2013 and under OMEPRAZOLE 1989-2006
History Note: 2014
DeCS ID: 55245
Unique ID: D064747
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2014/01/01
Date of Entry: 2013/07/08
Revision Date: 2017/01/17
Lansoprazole - Preferred
Concept UI M0583189
Scope note A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Preferred term Lansoprazole
Entry term(s) 2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)benzimidazole
Lansoprazol
Lansoprazoles
Ogastro - Narrower
Concept UI M000623490
Preferred term Ogastro
AG 1749 - Narrower
Concept UI M0163554
Preferred term AG 1749
Entry term(s) AG-1749
AG1749
Agopton - Narrower
Concept UI M0451577
Preferred term Agopton
Bamalite - Narrower
Concept UI M0451578
Preferred term Bamalite
Lansol - Narrower
Concept UI M0583197
Preferred term Lansol
Lansoprazole Sodium - Narrower
Concept UI M0583262
Preferred term Lansoprazole Sodium
Entry term(s) Sodium, Lansoprazole
Lanzor - Narrower
Concept UI M0451624
Preferred term Lanzor
Monolitum - Narrower
Concept UI M0451625
Preferred term Monolitum
Opiren - Narrower
Concept UI M0451638
Preferred term Opiren
Prevacid - Narrower
Concept UI M0163556
Preferred term Prevacid
Pro Ulco - Narrower
Concept UI M0451639
Preferred term Pro Ulco
Promeco - Narrower
Concept UI M0451618
Preferred term Promeco
Takepron - Narrower
Concept UI M0446691
Preferred term Takepron
Ulpax - Narrower
Concept UI M0451640
Preferred term Ulpax
Zoton - Narrower
Concept UI M0451641
Preferred term Zoton
Ogast - Narrower
Concept UI M000623488
Preferred term Ogast
Prezal - Narrower
Concept UI M000623489
Preferred term Prezal



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey